Under MoCRA, who is the “responsible person” for U.S. cosmetic product listing for baby care items?

Under MoCRA, the “responsible person” for FDA cosmetic product listing is the manufacturer, packer, or distributor whose name appears on the U.S. product label (typically your U.S. brand owner entity). For an overseas OEM like LAEYO, it is usually not us unless our name is on the label.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • For U.S. baby care cosmetics, FDA looks to the “responsible person” as the manufacturer, packer, or distributor named on the product label.
  • In practice, for Amazon sellers this is often your U.S. brand company (or a U.S. distributor you appoint) since they control labeling and will submit the product listing.
  • As your Guangzhou OEM/ODM partner, LAEYO can support you with the technical file inputs you will need for listing readiness (formula/INCI draft, product specs, and supporting test/doc packages).
  • We can also coordinate third-party testing and track test reports, plus provide concept positioning, pack copy/IFU drafting, and full VI + packaging design services.
  • MOQ can be structured for a small launch run first, then scale; final MOQ depends on the chosen formula and packaging components.
  • For timelines, turnkey brand landing is typically 45-60 days end-to-end.
  • Bulk production is commonly 10-20 working days after final sample confirmation, while packaging ordering often takes 10-30 working days (e.g., unit box 15 days, set box 20; glass bottle 15, acrylic 30; tube 15; mask pouch 15).
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).